| Literature DB >> 25140083 |
Hugo Pasini Neto1, Luanda André Collange Grecco2, Natália Almeida Carvalho Duarte3, Thaluanna Calil Lourenço Christovão3, Luis Vicente Franco de Oliveira4, Arislander Jonathan Lopes Dumont3, Manuela Galli5, Claudia Santos Oliveira4.
Abstract
[Purpose] Improved gait efficiency is one of the goals of therapy for children with cerebral palsy (CP). Postural insoles can allow more efficient gait by improving biomechanical alignment. The aim of the present study was to assess the effect of postural insoles on gait performance of children with CP classified as levels I or II of the Gross Motor Function Classification System (GMFCS).Entities:
Keywords: Cerebral palsy; Orthoses; Postural insole
Year: 2014 PMID: 25140083 PMCID: PMC4135184 DOI: 10.1589/jpts.26.1003
Source DB: PubMed Journal: J Phys Ther Sci ISSN: 0915-5287
Fig. 1.Representation figure of the elements used in postural insoles A- half-moon; B- anti-valgus (Podaly®).
Fig. 2.The representation of placebo insole used by the control group (Podaly®).
Fig. 3.Fluxogram
The anthropometric characteristics of the sample
| Anthropometric data | |||
|---|---|---|---|
| Age (years) | Height (cm) | Body mass (kg) | |
| Mean | 8 | 123 | 20 |
| Standard deviation | 2.9 | 35 | 5.2 |
Mean ± SD of anthropometric data of participants
Gait variables when barefoot, wearing shoes without insoles and wearing shoes with postural insoles (EG) or shoes with placebo insole (CG)
| Barefoot | Shoes without insole | Shoes with insoles | ||||
|---|---|---|---|---|---|---|
| EG | CG | EG | CG | EG | CG | |
| Support phase (%) | 55.3 (5.4) | 55.3 (2.3) | 46.0 (9.6) | 48.6 (11.2) | 53.8 (4.8) | 51.4 (5.3) |
| Swing phase (%) | 41.6 (3.0) | 42.0 (3.7) | 37.6 (9.1) | 41.9 (4.3) | 40.0 (2.1) | 43.1 (6.7) |
| Double support phase (%) | 5.1 (1.6) | 6.2 (1.6) | 6.7 (9.1) | 6.4 (1.6) | 10.9 (4.7) | 20.0 (28.6) |
| Step time (s) | 0.83 (0.12) | 0.96 (0.18) | 0.91 (0.17) | 1.06 (0.23) | 0.90 (0.20) | 0.98 (0.17) |
| Cadence (step/min) | 111.5 (18.7) | 111.0 (20.7) | 87.7 (25.1) | 99.9 (27.4) | 124.9 (7.0)* | 99.2 (25.9) |
| Step length (m) | 0.34 (0.10) | 0.33 (0.06) | 0.34 (0.14) | 0.33 (0.06) | 0.32 (0.91) | 0.33 (0.05) |
| Stride length (m) | 0.78 (0.21) | 0.75 (0.15) | 0.67 (0.19) | 0.71 (0.12) | 0.79 (0.19) | 0.71 (0.13) |
| Velocity (m/s) | 0.89 (0.10) | 0.81 (0.17) | 0.83 (0.13) | 0.82 (0.09) | 0.98 (0.13)*# | 0.84 (0.17) |
*p ≤ 0.05 (intra-group analysis − repeated-measure ANOVA); # p ≤ 0.05 (inter-group analysis − independent t-test)
Effect of treatment on all outcome measures
| Shoes with postural insoles | |||
|---|---|---|---|
| EG | CG | Effect | |
| Support phase (%) | 7.8 (−7.3–22.9) | 2.7 (−5.8–11.3) | 5.05 |
| Swing phase (%) | 2.4 (−11.0–15.0) | 1.1 (−4.0–6.4) | 1.21 |
| Double support phase (%) | 13.6 (−21.1–48.3) | 4.1 (−1.6–9.9) | −9.46 |
| Step time (s) | −0.04 (−0.1–0.1) | 0.07 (−0.1–0.3) | 0.07 |
| Cadence (step/min) | 37.1 (11.0–63.2) | −0.78 (−16.9–15.3) | 37.92* |
| Step length (m) | 0.06 (−0.00–0.02) | −0.1 (−0.1–0.08) | −0.02 |
| Stride length (m) | 0.06 (−0.008–0.02) | −0.01 (−0.01–0.08) | 0.12 |
| Velocity (m/s) | 0.14 (−0.03–0.32) | −0.08 (−0.02–0.04) | 0.22* |
*p ≤ 0.05 (inter-group analysis − Independent t-test)